Enhancement of the Functional Repertoire of the Rat Parietal Peritoneal MesotheliumIn Vivo: Directed Expression of the Anticoagulant and Antiinflammatory Molecule Thrombomodulin
| Autor: | V. Susan Harvey, Michelle S. Meyers, Elizabeth M. Masse, Robert W. Jackman, Teresa D. Stapleton, Ty R. Shockley, Janice A. Nagy |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
medicine.drug_class
Recombinant Fusion Proteins Thrombomodulin Genetic enhancement Genetic Vectors Anti-Inflammatory Agents Gene Expression Biology Transfection In vivo Genetics medicine Animals Peritoneal Cavity Molecular Biology Gene Peritoneal mesothelium Tumor Necrosis Factor-alpha Anticoagulant Gene Transfer Techniques Anticoagulants Epithelial Cells Blotting Northern Precipitin Tests Molecular biology Rats Inbred F344 Rats Cancer research Molecular Medicine Cattle Female Rabbits Ex vivo Mesothelial Cell Plasmids |
| Zdroj: | Human Gene Therapy. 9:1069-1081 |
| ISSN: | 1557-7422 1043-0342 |
| DOI: | 10.1089/hum.1998.9.7-1069 |
| Popis: | We have used our previously described ex vivo mesothelial cell (MC)-mediated gene therapy strategy (Gene Ther. 2:393-401, 1995) to modify the functional properties of the rat parietal peritoneal mesothelium in vivo by expression of a membrane-bound recombinant protein on the MC surface. Rat primary MCs were stably transfected (using strontium phosphate DNA coprecipitation) with a plasmid containing the gene for rat thrombomodulin (TM), a transmembrane glycoprotein that functions as an essential cofactor for the physiological activation of the anticoagulant protein C by the enzyme thrombin. As demonstrated by immunohistochemistry and by direct equilibrium binding with radiolabeled thrombin, genetically modified MCs expressed high levels of TM antigen on their surface in vitro. As judged by a thrombin-dependent protein C activation assay, such MC membrane-bound TM was biologically active. Once reseeded on the denuded parietal peritoneal surface of syngeneic recipients, these TM-transfected MCs continued to express TM antigen in vivo for at least 90 days. Moreover, the recombinant TM expressed on the reconstituted parietal mesothelium retained its ability to activate protein C in a thrombin-dependent manner. Our data indicate that MC-mediated expression of TM can be used to augment the anticoagulant properties of the parietal peritoneal surface. In general, our results suggest that ex vivo MC-mediated gene therapy can be used to deliver other therapeutic transmembrane proteins to the MC surface to enhance the functional repertoire of the parietal mesothelium in vivo. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|